Rabies Vaccine for Human Use(Ningbo Rongan Biological Pharmaceutical Co Ltd)

Main research objectives 1. To evaluate the non-inferiority of the immunogenicity of the 5-dose group of the test vaccine to the 5-dose group of the control vaccine; 2. To evaluate the non-inferiority of the immunogenicity of the 4-dose group of the test vaccine to the 5-dose group of the control vaccine. Secondary objectives 1. To evaluate the immunogenicity of the 5-dose group of the test vaccine compared with the 5-dose group of the control vaccine; 2. To evaluate the immunogenicity of the 4-dose group of the test vaccine compared with the 5-dose group of the control vaccine; 3. To evaluate the immunogenicity of the 4-dose group of the test vaccine compared with the 5-dose group of the test vaccine; 4. To evaluate the immune persistence of the test vaccine; 5. To evaluate the safety of the test vaccine compared with the control vaccine.